全球药品品管市场规模、份额、趋势和成长分析报告（2026-2034年）

预计到 2034 年，药品品管市场规模将从 2025 年的 66 亿美元成长至 188.6 亿美元，2026 年至 2034 年的复合年增长率为 12.38%。

由于监管要求日益严格以及药物研发活动的不断增加，全球药品品管市场正稳步扩张。品管流程确保药品的安全性、有效性以及符合国际标准。随着学名药药和生物製药产量的增加，製药公司正大力投资先进的分析检测解决方案。对药品生产品质管理规范 (GMP) 的日益重视也进一步推动了对品管系统的需求。

关键成长要素包括层析法、光谱和分子检测技术等分析仪器的进步。生物製药和生物相似药日益复杂，需要更精确的检测和检验流程。此外，将品质检测外包给受託研究机构(CRO) 的趋势日益增长，也促进了市场成长。全球监管机构实施更严格的合规标准，也推动了对检测基础设施投资的增加。

随着全球医药创新持续发展，未来前景依然强劲。个人化医疗和先进疗法的兴起对更精密的品管技术提出了更高的要求。在新兴市场，法规结构的不断改进进一步推动了市场需求。自动化数位资料管理系统有望提升营运效率，进而促进医药品管市场的永续发展。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球药品品管市场：依产品划分

• 市场分析、洞察与预测
• 消耗品
• 装置
• 服务

第五章：全球医药品管市场：依分析类型划分

• 市场分析、洞察与预测
• 无菌测试
• 微生物附着量测试
• 内毒素试验
• 稳定性测试
• 萃取和洗脱试验
• 原料测试
• 其他的

第六章：全球药品品管市场：依产品测试划分

• 市场分析、洞察与预测
• 疫苗
• 血浆製剂
• 製药

第七章 全球医药品管市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • BioMerieux SA
  • SGS SA
  • Charles River Laboratories International Inc
  • WiXi AppTec
  • Merck KGaA
  • Thermo Fisher Scientific Inc
  • Toxikon Corporation
  • Sartorius AG
  • REMI Group
  • Perkin Elmer

The Pharmaceutical Quality Control Market size is expected to reach USD 18.86 Billion in 2034 from USD 6.60 Billion (2025) growing at a CAGR of 12.38% during 2026-2034.

The Global Pharmaceutical Quality Control Market is expanding steadily due to stringent regulatory requirements and increasing drug development activities. Quality control processes ensure safety, efficacy, and compliance with global standards. With rising production of generic drugs and biologics, pharmaceutical companies are investing heavily in advanced analytical testing solutions. Growing emphasis on Good Manufacturing Practices (GMP) further drives demand for quality control systems.

Major growth drivers include advancements in analytical instruments such as chromatography, spectroscopy, and molecular testing technologies. The rising complexity of biologics and biosimilars requires precise testing and validation processes. Additionally, increasing outsourcing of quality testing to contract research organizations is contributing to market growth. Regulatory authorities worldwide are enforcing stricter compliance norms, boosting investment in testing infrastructure.

Future prospects remain strong as pharmaceutical innovation continues to expand globally. The growth of personalized medicine and advanced therapies will require more sophisticated quality control techniques. Emerging markets are strengthening regulatory frameworks, further driving demand. Automation and digital data management systems are expected to enhance operational efficiency, positioning the pharmaceutical quality control market for sustained development.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Consumables
• Instruments
• Services

By Analysis Type

• Sterility Testing
• Bioburden Testing
• Endotoxin Testing
• Stability Testing
• Extractable & Leachable Testing
• Raw Material Testing
• Others

By Products Tested

• Vaccines
• Plasma Products
• Drugs

COMPANIES PROFILED

• BioMerieux SA, SGS SA, Charles River Laboratories International Inc, WiXi AppTec, Merck KGaA, Thermo Fisher Scientific Inc, Toxikon Corporation, Sartorius AG, REMI Group, Perkin Elmer
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PHARMACEUTICAL QUALITY CONTROL MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PHARMACEUTICAL QUALITY CONTROL MARKET: BY ANALYSIS TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Analysis Type
• 5.2. Sterility Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Bioburden Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Endotoxin Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Stability Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Extractable & Leachable Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Raw Material Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PHARMACEUTICAL QUALITY CONTROL MARKET: BY PRODUCTS TESTED 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Products Tested
• 6.2. Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Plasma Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PHARMACEUTICAL QUALITY CONTROL MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Analysis Type
  • 7.2.3 By Products Tested
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Analysis Type
  • 7.3.3 By Products Tested
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Analysis Type
  • 7.4.3 By Products Tested
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Analysis Type
  • 7.5.3 By Products Tested
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Analysis Type
  • 7.6.3 By Products Tested
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PHARMACEUTICAL QUALITY CONTROL INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 BioMerieux SA
  • 9.2.2 SGS S.A
  • 9.2.3 Charles River Laboratories International Inc
  • 9.2.4 WiXi AppTec
  • 9.2.5 Merck KGaA
  • 9.2.6 Thermo Fisher Scientific Inc
  • 9.2.7 Toxikon Corporation
  • 9.2.8 Sartorius AG
  • 9.2.9 REMI Group
  • 9.2.10 Perkin Elmer